Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2/3 1

Status

Completed 32Recruiting 4Terminated 3Not yet recruiting 3Withdrawn 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Venous Thromboembolism 1Pulmonary Embolism 1Peripheral Nervous System Diseases 1Neoplasms 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Carboplatin 126Cisplatin 125Drug Therapy 103Bevacizumab 98Oxaliplatin 97Capecitabine 97Radiotherapy 94Gemcitabine 87Paclitaxel 85tislelizumab 84Cyclophosphamide 82pembrolizumab 77Specimen Handling 77toripalimab 69Injections 63Fluorouracil 62Magnetic Resonance Spectroscopy 61sintilimab 57anlotinib 53130-nm albumin-bound paclitaxel 51Surgical Procedures, Operative 50Docetaxel 49fludarabine 46Pemetrexed 45venetoclax 42Standard of Care 42Leucovorin 42Irinotecan 41lenvatinib 40Biopsy 39

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Rosuvastatin Calcium × Clear all
NCT07303816 2026-06-01

STAT-CAT

Brigham and Women's Hospital

Phase 4 Not yet recruiting
4,000 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thromboembolism

NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Tanta University

Phase 2/3 Not yet recruiting
46 enrolled

Peripheral Nervous System Diseases

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting
400 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡